Does Sangamo Have the Best Gene Therapy Program Now?

Sangamo Therapeutics (NASDAQ: SGMO) recently thrilled investors with an update for its experimental gene therapy. It looks like SB-525 can help people with a rare bleeding disorder called hemophilia A, but it isn't the only potential new treatment for this condition.